<DOC>
	<DOCNO>NCT00212823</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety AXERT treat migraine onset headache pain , compare treat migraine headache pain reach least moderate intensity..</brief_summary>
	<brief_title>The Effectiveness Almotriptan Malate ( AXERT® ) 12.5 Milligrams When Taken Onset Migraine Pain</brief_title>
	<detailed_description>AXERT approve FDA treatment migraine headache without aura adult . Early treatment migraine headache , independent headache pain intensity symptom , may provide optimal therapeutic response . This multi-center , open label study test efficacy ( effectiveness ) tolerability AXERT treat migraine onset headache pain versus treat migraine headache pain reach least moderate intensity . Patients self-administer 12.5 milligram AXERT treatment 2 migraine headache . Centers randomly assign 1 2 treatment intervention patient sequentially treat migraine headache 12.5 milligram AXERT use either early treatment regimen ( ET ; ie , onset pain ) conditional treatment regimen ( CT ; ie , headache reach least moderate intensity ) . Data collect regard treatment response migraine headache . For headache , patient record study information data 3 telephone call use Interactive Voice Response System ( IVRS ) technology . It expect patient take 12.5 milligram AXERT first sign pain intensity due migraine headache experience overall short duration migraine patient take AXERT 12.5 mg migraine pain reach least moderate pain intensity . In addition , expect almotriptan malate ( AXERT® ) generally well-tolerated . AXERT 12.5 milligram tablet orally either onset migraine pain ( within 1 hour start migraine-ET regimen ) migraine pain reach least moderate intensity ( CT regimen ) .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Almotriptan</mesh_term>
	<criteria>History confirm diagnosis migraine headache without aura meet International Headache Society ( IHS ) criteria migraine headache least 1 year Average frequency 1 6 migraine headache per month past 3 month History migraine headache least moderate pain intensity within past year If take medication migraine prophylaxis , take maintenance dose least 4 week prior Visit 1 , remain stable dose duration study In generally good health Capable take oral medication , perform study procedure follow direction regard collection study information , e.g. , subject must able willing read comprehend write instruction , use stopwatch , comprehend complete telephone requirement , must willing return office final study visit If female childbearing potential , use birth control Onset migraine age 50 Chronic migraine chronic tensiontype headache define 15 headache day per month previous 6 month Exclusively migraine aura without headache , headache occur predominantly upon awaken morning Patients triptans contraindicate previously discontinue AXERT therapy due adverse event , history substance abuse , chronic alcohol abuse within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Migraine</keyword>
</DOC>